Skip to Main Content
×
Quiver Logo Get a Free Trial on Quiver Premium Today!
Back to News

Option Care Health slides as Q1 revenue misses expectations and 2026 outlook is lowered

None

Option Care Health (OPCH) is down 29.1% today. Here is some analysis on what might have caused this price movement.

Analysis: The selloff appears tied to the company’s first-quarter 2026 results, where revenue came in below consensus expectations and management lowered its full-year 2026 revenue outlook. Investors also seemed to react to softer profitability metrics (Adjusted EBITDA down year over year) and negative operating cash flow in the quarter.

Details:

  • Option Care Health posted first-quarter 2026 net revenue of $1.3507 billion (+1.3% year over year) and Adjusted diluted EPS of $0.40.
  • Street expectations for the quarter were higher on revenue (roughly $1.40 billion), even though EPS was broadly in line to slightly better than estimates.
  • Management updated full-year 2026 guidance to net revenue of $5.675 billion to $5.775 billion, alongside adjusted EPS of $1.82 to $1.92 and Adjusted EBITDA of $480 million to $505 million.
  • The company reported cash used in operating activities of $12.1 million in Q1, which may have amplified concerns about near-term fundamentals.
  • Sources:

    Option Care Health Investor Relations, MarketBeat, RTTNews

    Disclaimer: This price movement analysis was generated with the help of AI. Please double-check the information provided for mistakes.

    EARLY ACCESS
    Receive OPCH Data Alerts
    Real-time alerts on filings, insider trades, and market signals — before everyone else.
    Get Alerts →

    $OPCH Hedge Fund Activity

    We have seen 156 institutional investors add shares of $OPCH stock to their portfolio, and 230 decrease their positions in their most recent quarter.

    Here are some of the largest recent moves:

    To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API.

    $OPCH Congressional Stock Trading

    Members of Congress have traded $OPCH stock 3 times in the past 6 months. Of those trades, 1 have been purchases and 2 have been sales.

    Here’s a breakdown of recent trading of $OPCH stock by members of Congress over the last 6 months:

    • REPRESENTATIVE LISA C. MCCLAIN has traded it 3 times. They made 1 purchase worth up to $15,000 on 10/30 and 2 sales worth up to $30,000 on 10/31, 10/30.

    To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard. You can access data on congressional stock trades through the Quiver Quantitative API.

    $OPCH Price Targets

    Multiple analysts have issued price targets for $OPCH recently. We have seen 7 analysts offer price targets for $OPCH in the last 6 months, with a median target of $38.0.

    Here are some recent targets:

    • Michael Petusky from Barrington Research set a target price of $42.0 on 01/16/2026
    • Constantine Davides from Citizens set a target price of $38.0 on 01/13/2026
    • Erin Wright from Morgan Stanley set a target price of $38.0 on 01/13/2026
    • Raj Kumar from Stephens & Co. set a target price of $40.0 on 12/11/2025
    • Kevin Fischbeck from B of A Securities set a target price of $35.0 on 12/09/2025
    • Pito Chickering from Deutsche Bank set a target price of $36.0 on 12/09/2025
    • Charles Rhyee from TD Cowen set a target price of $27.0 on 11/03/2025

    This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.

    Add Quiver Quantitative to your preferred sources on Google Google News Logo

    Suggested Articles